Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Fluffy Unicorn (2017-08-03)

Report a Concern
Starting date:
August 3, 2017
Posting date:
August 9, 2017
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-64192

Reason

Product sold without market authorization (NPN) in Canada. Product contains undeclared synephrine that in combination with caffeine may pose a risk to health.

Depth of distribution

Retailers

Affected products

Fluffy Unicorn

DIN, NPN, DIN-HIM

No market authorization

Dosage form

Powder

Strength

500mg (4-Amynobutyl) guanidinium sulphate
200mg 1,3,7-Trimethylxanthine
2300mg 2-aminoethanesulfonic acid
5000mg Citrulline malate
1000mg Glycine, N- (aminoiminoMethyl) -N-Methyl-, monohydrochloride

Lot or serial number

All Lots

Companies

Recalling Firm
Distribution Limitless
8705 Rue Magloire-Lavallée
Mirabel
J7N OX9
Quebec
CANADA
Marketing Authorization Holder
Not Applicable